Related Experiment Videos
Hypertrophic cardiomyopathy. Clinical spectrum and treatment
E D Wigle1, H Rakowski, B P Kimball
1Division of Cardiology, Toronto Hospital, Ontario, Canada.
Circulation
|October 1, 1995
Insights
Hypertrophic cardiomyopathy (HCM) is a complex disease with diverse characteristics. Recognizing this heterogeneity is key to tailoring treatments for individual patient needs and predominant abnormalities.
Area of Science:
- Cardiology
- Genetics
- Pathophysiology
Background:
- Hypertrophic cardiomyopathy (HCM) presents as a genetically and phenotypically diverse condition.
- The disease exhibits significant heterogeneity across pathophysiological, clinical, and therapeutic aspects.
Purpose of the Study:
- To emphasize the importance of acknowledging the heterogeneity of HCM.
- To guide therapeutic strategies based on predominant patient abnormalities.
Main Methods:
- This study is a review and synthesis of existing knowledge on HCM heterogeneity.
- Analysis of genotypic, phenotypic, and clinical data to identify patterns.
Main Results:
- HCM is characterized by significant variability in its genetic underpinnings.
- Phenotypic expression and clinical presentation of HCM are highly diverse.
- Pathophysiological mechanisms and therapeutic responses vary considerably among patients.
Conclusions:
- Effective management of HCM requires a personalized approach.
- Therapies should be directed towards the specific abnormalities identified in each patient to optimize outcomes.
Abstract:
HCM is a heterogeneous disease genotypically, phenotypically, pathophysiologically, clinically, and therapeutically. In decisions on the management of these patients, it is important to recognize this heterogeneity and to direct therapy at the predominant abnormalities.